磁共振波谱在预测成人心脏骤停后昏迷患者良好结局中的效用
该研究纳入94例接受MRI及同期MRS的昏迷心脏骤停患者,主要终点为出院时昏迷恢复(25例,27%),次要终点为6个月时良好神经功能(CPC 1-2,22例,23%)。后扣带回NAA/Cr对昏迷恢复的鉴别力最强(中位数1.29 vs 0.86,P<0.0001),AUROC为0.9(95%CI 0.84-0.96),对6个月良好结局的AUROC为0.88(95%CI 0.82-0.95),显著优于所有定量ADC测量,仅对次要终点与后扣带回平均ADC的差异未达统计学显著(校正P=0.064)。将MRS加入已有早期良好结局预测指标,在100%敏感度下特异度从67%升至93%。作者认为后扣带回NAA/Cr是预测心脏骤停后昏迷患者良好结局的有价值指标,但需进一步研究优化MRS采集以用于多模态神经预后评估。
要点
- 94例昏迷心脏骤停患者中,25例(27%)出院时昏迷恢复,22例(23%)6个月时CPC 1-2。
- 后扣带回NAA/Cr预测昏迷恢复的AUROC为0.9(95%CI 0.84-0.96),对6个月良好结局的AUROC为0.88(95%CI 0.82-0.95)。
- 后扣带回NAA/Cr预测昏迷恢复显著优于所有定量ADC测量;对6个月良好结局仅与后扣带回平均ADC的差异未达统计学显著(校正P=0.064)。
- 将MRS加入已有早期良好结局预测指标,在100%敏感度下特异度从67%提高至93%。
- 含NAA/Cr或ADC联合临床与EEG变量的多变量模型较仅含临床与EEG变量的模型表现改善,但差异未达统计学显著。
适用人群与场景
- 接受MRI及同期MRS检查的成人心脏骤停后昏迷患者。
诊断标准与关键阈值
- 主要终点:出院时昏迷恢复。
- 次要终点:6个月时良好神经功能,定义为脑功能表现分类(CPC)1-2,对照CPC 3-5。
- 在后扣带回、顶叶白质和脑干测量6种代谢物。
- 计算全脑及特定区域的平均ADC值,以及ADC<450和<650×10⁻⁶×mm²/s的体素百分比。
研究设计与关键结果
- 研究类型:采用MRI及同期MRS评估心脏骤停后昏迷患者预后的研究;样本量94例;25例(27%)出院时昏迷恢复,22例(23%)6个月时良好结局(CPC 1-2)。
- 后扣带回NAA/Cr对昏迷恢复的鉴别力最强:昏迷恢复组中位数1.29(IQR 0.21)vs 未恢复组0.86(IQR 0.32),P<0.0001。
- 后扣带回NAA/Cr对昏迷恢复的AUROC为0.9(95%CI 0.84-0.96),对6个月良好结局的AUROC为0.88(95%CI 0.82-0.95),显著优于所有定量ADC测量,仅对次要终点与后扣带回平均ADC的差异未达统计学显著(校正P=0.064)。
- 含NAA/Cr或ADC联合临床与EEG变量的多变量模型较仅含临床与EEG变量的模型表现改善,但差异未达统计学显著。
- 将MRS加入已有早期良好结局预测指标,在100%敏感度下特异度从67%提高至93%。
证据类型、等级与局限
- 证据类型:研究论文(预后研究)。
- 局限:需进一步研究以优化MRS采集用于多模态神经预后评估。
对床旁实践的改变
- 作者认为后扣带回NAA/Cr是预测心脏骤停后昏迷患者良好结局的有价值指标,对昏迷恢复的预测优于定量ADC测量。
- 将MRS加入已有早期良好结局预测指标,可在100%敏感度下将特异度从67%提高至93%,但含NAA/Cr或ADC的多变量模型较仅含临床与EEG变量的模型改善未达统计学显著。
- 作者建议需进一步研究优化MRS采集以用于多模态神经预后评估。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: To correlate brain metabolites with clinical outcomes using magnetic resonance spectroscopy (MRS) in cardiac arrest (CA) patients and assess their prognostic performance compared to quantitative apparent diffusion coefficient (ADC) maps.
METHODS: Comatose CA patients who underwent MRI and concurrent MRS were included.
PRIMARY OUTCOME: coma recovery at hospital discharge; secondary outcome: good neurological function at 6 months (Cerebral Performance Index 1-2, vs. 3-5). Six metabolites were measured in the posterior cingulate gyrus (PCG), parietal white matter, and brainstem. Mean ADC values, and percentage of voxels with ADC <450 and <650 × 10-6 × mm2/s were computed for whole brain and specific regions. Prognostic performance was compared using Receiver Operating Characteristic (ROC) curves.
RESULTS: Of 94 patients, 25 (27 %) achieved coma recovery, and 22 (23 %) had a good outcome at 6 months. N-acetylaspartate/Creatine (NAA/Cr) in the PCG was most discriminative for coma recovery (median 1.29, IQR 0.21 vs. 0.86, 0.32; p-value <0.0001). NAA/Cr had the highest area under the curve for coma recovery (0.9, 95 % CI 0.84-0.96) and good outcome at 6 months (AUROC 0.88, 95 % CI 0.82-0.95), significantly outperforming all quantitative ADC measurements, except mean ADC of the PCG for the secondary outcome (adj. p-value = 0.064). Multivariable models incorporating NAA/Cr or ADC, alongside clinical and EEG variables, demonstrated improved performance compared to models with clinical and EEG variables alone, though the difference was not statistically significant. Adding MRS to established early predictors of favorable outcome increased the specificity from 67 % to 93 % at 100 % sensitivity.
CONCLUSION: MRS-derived NAA/Cr in the PCG is a valuable predictor of good outcome in comatose CA patients, outperforming quantitative ADC measurements for coma recovery. Further studies are needed to optimize MRS acquisition for multimodal neuroprognostication.
参考来源
- Fisch U, Breedlove K, Scirica BM, et al. Utility of magnetic resonance spectroscopy in predicting favorable outcome in adult comatose patients following cardiac arrest. Resuscitation. 2025. PMID: 40582486. doi:10.1016/j.resuscitation.2025.110700
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。